Dr. Abazeed's lab focuses on understanding the complexities of small cell lung carcinoma (SCLC), a challenging type of cancer that is often resistant to treatment. The lab explores how cancer cells can change their behavior and characteristics in response to therapies, which helps uncover new strategies for overcoming these resistances. By studying the different states of SCLC cells, the team aims to develop innovative therapeutic approaches that can improve treatment outcomes for patients.

Dr. Michael Markl's lab at Northwestern University focuses on advancing cardiac imaging techniques to improve patient outcomes in heart diseases. They are developing state-of-the-art MRI technology, particularly four-dimensional (4D) flow MRI and cardiac MRI, to assess blood flow and tissue health in individuals with congenital heart defects and heart transplant patients. The lab uses artificial intelligence to streamline imaging processes and enhance analysis accuracy, ultimately aiming to establish non-invasive methods for better predicting and managing heart complications.

Dr. Priyanka Gopal's research lab at Northwestern University focuses on understanding how genetic features influence the effectiveness of radiotherapy in lung cancer treatment. The lab works on characterizing treatment resistance and aims to develop personalized therapies based on genetic markers. They conduct extensive genomic studies and utilize preclinical models to improve patient outcomes in cancer care, especially for those undergoing radiotherapy.

Dr. Hao F Zhang's lab focuses on advancing glaucoma diagnosis and treatment through innovative imaging techniques. Their main project involves developing a novel visible-light optical coherence tomography (vis-OCT) system that can visualize retinal structures and measure oxygen levels in the eye more accurately than existing technologies. This work aims to detect early signs of glaucoma and monitor its progression, ultimately improving patient care.

Dr. Laleh Golestani Rad's lab focuses on improving the safety of patients with implantable medical devices who require MRI scans. They research how radiofrequency heating can affect these devices, particularly in low-field MRI systems. Their goal is to create safe imaging practices that will allow more patients to benefit from necessary MRI diagnostics without risking injury.

Dr. Mohammed Elbaz's lab at Northwestern University is focused on revolutionizing the diagnosis and management of pulmonary hypertension (PH), particularly its severe form known as pulmonary arterial hypertension (PAH). By developing a groundbreaking non-invasive tool called the '4D Right-Heart Virtual Catheter', the lab aims to dramatically improve how healthcare providers can assess the hemodynamics of the right heart using advanced MRI scans. This innovative approach not only seeks to expedite the diagnostic process but also hopes to enhance treatment outcomes for patients suffering from this life-threatening condition.

Dr. Robert J Lewandowski's lab focuses on improving treatment options for patients with liver cancer, specifically unresectable hepatocellular carcinoma (HCC). The lab is investigating a new technique called Yttrium-90 radiation lobectomy (90Y-RL) that could help shrink tumors while promoting healthy liver regrowth. Their research aims to optimize the dosage and technique of this treatment to better support patients who are not candidates for surgery due to liver conditions.

Dr. Dong-Hyun Kim's lab focuses on developing innovative treatments for liver cancer using a combination of immunotherapy and radioembolization techniques. The lab is dedicated to enhancing the effectiveness of immune checkpoint blockades by targeting them specifically to tumor sites, potentially improving patient outcomes. Their research aims to make therapies safer and more effective, with the ultimate goal of treating patients who would otherwise have limited options.

Dr. Eric Jon Perreault's lab focuses on improving rehabilitation techniques by developing noninvasive methods to assess muscle function and structure. They study how muscle stiffness and force can impact movement, especially in patients with disorders like stroke or cerebral palsy. By utilizing advanced ultrasound techniques, the lab aims to provide accurate measurements that can enhance recovery protocols for individuals with musculoskeletal injuries.

Ulas Bagci's lab focuses on harnessing advanced deep learning techniques to predict the risk of pulmonary fibrosis in patients who have recovered from COVID-19. This research aims to identify early indicators that could lead to better therapeutic interventions and a deeper understanding of lung health post-infection. The lab combines imaging data, such as CT scans, with electronic health records to create comprehensive predictive models that address a pressing public health need.

Dr. Gayle E. Woloschak's research lab focuses on understanding the effects of internal exposure to radionuclides, which can occur due to accidents or medical treatments. They study how these radionuclides distribute within different organs at various scales, from cellular to tissue levels, to improve protective measures for health and safety. The lab combines various scientific disciplines such as radiation physics, chemistry, and biology to develop better models and countermeasures against the harmful effects of radiation exposure.

Dr. Guillermo Antonio Ameer's research focuses on improving wound healing for diabetic patients. His lab develops innovative medical devices, particularly a smart bandage that not only promotes healing but also monitors wound conditions in real time. This work aims to reduce complications like infections and amputations associated with diabetic foot ulcers.

Dr. Lirong Yan's lab at Northwestern University focuses on understanding how changes in blood vessels in the brain affect cognitive decline and dementia, particularly in Alzheimer's disease and vascular cognitive impairment. The team uses advanced imaging techniques to create precise measurements of brain blood vessel health, aiming to develop new biomarkers that can help differentiate between various types of vascular-related cognitive issues. This research could lead to better diagnostic tools and treatments for dementia-related conditions.